A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
about
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgeryAnticoagulation management in mechanical circulatory supportHeparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrumsDirect thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: treatment options and special considerations.Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin allergy.Bivalirudin for patients with heparin-induced thrombocytopenia undergoing cardiovascular surgery.Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudinSuccessful use and dosing of bivalirudin after temporary total artificial heart implantation: a case series.Bivalirudin anticoagulation during cardiac surgery: a single-center experience in 141 patients.Heart transplantation using bivalirudin as anticoagulant.Bivalirudin: a review of the pharmacology and clinical application.Bivalirudin utilization in cardiac surgery: shifting anticoagulation from indirect to direct thrombin inhibition.Heparin-induced thrombocytopenia and extracorporeal membrane oxygenation: a case report and review of the literatureTreatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Pre-emptive use of bivalirudin for emergent off-pump coronary artery bypass surgery in a suspected case of heparin-induced thrombocytopeniaThrombosis during off pump LVAD placement in a patient with heparin induced thrombocytopenia using bivalirudin.Use of bivalirudin for anticoagulation during implantation of total artificial heart.Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin-induced thrombocytopenia-reactive antibodies or with true HIT (HIT-reactive antibodies plus thrombocytopenia): An 11-year experience.Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery.Cardiopulmonary Bypass Without Heparin.Bivalirudin for Alternative Anticoagulation in Extracorporeal Membrane Oxygenation: A Systematic Review.Heparin-Induced Thrombocytopenia in Cardiac Surgery Patients.Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass.Specificity and selectivity profile of EP217609: a new neutralizable dual-action anticoagulant that targets thrombin and factor XaBivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenationArgatroban for anticoagulation during cardiac surgery.Antithrombotic therapy for the CardioWest temporary total artificial heart.Pathophysiology of Cardiopulmonary Bypass: Current Strategies for the Prevention and Treatment of Anemia, Coagulopathy, and Organ Dysfunction.Extracorporeal Membrane Oxygenation Applications in Cardiac Critical Care.Bivalirudin and post-cardiotomy ECMO: a word of caution.Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox®) anticoagulation.Bivalirudin for prevention of prosthetic valve thrombosis in heparin allergy.2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery.Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study.
P2860
Q24187077-73FCC6BB-64F6-40B0-87E5-0F7023189F1AQ26770302-E7B03399-194C-418D-8D88-390ACB757D3DQ26799395-F8B4F610-E999-49A2-AB42-E7BC8CB969A9Q33373700-961BF0C2-F6AD-4394-A69A-C7C80AC4F581Q33374658-EEEDAE57-A96D-4A05-974F-45F864EBF947Q33375899-65CFEBE3-3F77-44D1-9273-517DA494B407Q33380633-A034C7B6-5246-4395-91AB-DA663569FEDAQ33381356-159F7D7B-7C4D-4647-AF91-9995A6C0A07AQ33381805-32394C32-410A-4B64-9DD1-EFD831ACAFFDQ33385205-AD3EF408-168A-4595-B8C1-C0B3043BC4E9Q33386468-AA10A16A-4755-44E8-945B-26B335C74C3BQ33392973-E3995052-3714-4A38-9E14-2D2CA0DDFB79Q33393161-A1633074-B1D8-494F-8EB4-F92575FAEA8AQ33394695-E384BBD1-4342-4705-8489-F6F9A3F4281CQ33399580-1EB0FC36-2E3C-47D1-9BED-B3F253010ED2Q33400896-A38EFF7E-8A46-4E8B-9DD8-E597C85E9F31Q33407372-08C327F1-26E6-4DCD-8B21-42E75545ADE2Q33417601-1CD205CE-9211-4F67-A146-E47940993039Q33421448-866FBCD7-9ED7-4704-B407-0F3272958454Q33422490-D2D1FD6D-89ED-4D35-8A06-353BBA773F0DQ33430000-531342A0-E51E-4D0E-9DAC-35EE24AB48F3Q33433514-69D8ECAD-3909-4B9D-A2D2-BA04821BD289Q33442571-FE1FA03E-0109-4C37-976A-6D7F9F20DD04Q34817521-E3710BB2-3472-4021-B8C1-8DE3A012FC7CQ35849235-741BB81F-A32C-43D0-ACE2-F5B071603391Q36073211-3D8958FA-9B50-45C4-9285-C261A80C8207Q36747502-B7B33743-777F-4EF6-9ACB-7F7931BB8E8CQ37733290-EBEABEE5-9A89-4CE2-AE8B-BF4FF5DC2C97Q38215982-E7BE6E7E-4C32-469C-8BFA-CFA5CE90A444Q38592442-36088C4D-3A01-46BC-8A65-7E4F814A8DE1Q43241211-819A076C-9168-4814-9C92-6F15923B954BQ47265481-8DECA4C3-7F2D-4F0B-A560-9DB5E7F5FA05Q47875463-7EE011EF-8860-477D-AEA8-17A9C447F115Q50065194-D7A26ACC-6299-45C9-A918-1CA0449A576AQ51392267-DE20FD20-C59B-4EBB-8253-B21C5628A496
P2860
A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A comparison of bivalirudin to ...... ypass: the EVOLUTION-ON study.
@ast
A comparison of bivalirudin to ...... ypass: the EVOLUTION-ON study.
@en
type
label
A comparison of bivalirudin to ...... ypass: the EVOLUTION-ON study.
@ast
A comparison of bivalirudin to ...... ypass: the EVOLUTION-ON study.
@en
prefLabel
A comparison of bivalirudin to ...... ypass: the EVOLUTION-ON study.
@ast
A comparison of bivalirudin to ...... ypass: the EVOLUTION-ON study.
@en
P2093
P1476
A comparison of bivalirudin to ...... ypass: the EVOLUTION-ON study.
@en
P2093
A Michael Lincoff
Andreas Koster
Bruce D Spiess
Cornelius M Dyke
Harry L McCarthy
Nicholas G Smedira
Ronald Kirshner
Solomon Aronson
P304
P356
10.1016/J.JTCVS.2005.09.057
P407
P577
2006-03-01T00:00:00Z